SLC31A1 and neoplasm: Nine CRGs were differentially expressed between tumor and normal tissues, among which NFE2L2, SLC31A1, FDX1, DLD, DLAT, and DLST were lowly expressed in tumor tissues, and ATP7B, CDKN2A, and GCSH were highly expressed in tumor tissues (Figure 1A, p<0.05).